Attachment and Biobehavioral Catch-up for Depression
ABC
2 other identifiers
interventional
42
1 country
1
Brief Summary
The overarching goal is to pilot the Attachment and Biobehavioral Catch-up (ABC) intervention for mothers with heightened depressive symptom and their children with heightened internalizing symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 7, 2019
CompletedFirst Posted
Study publicly available on registry
August 8, 2019
CompletedStudy Start
First participant enrolled
August 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedResults Posted
Study results publicly available
July 22, 2024
CompletedJuly 22, 2024
July 1, 2024
2.2 years
August 7, 2019
December 18, 2023
July 18, 2024
Conditions
Outcome Measures
Primary Outcomes (2)
Change From Baseline in Internalizing Subscale Score of the Child Behavior Checklist (CBCL) at Week 10 (Value at Baseline Minus Value at Post Intervention (Week 10))
The internalizing subscale of the CBCL is a validated measure of emotional withdrawal, reactivity, sadness, anxiety, and other symptoms completed by mothers about their children. Scores range from 0 to 72 with higher scores indicating more severe symptoms.
Change in score from baseline at post-intervention (week 10).
Change From Baseline in Center for Epidemiologic Studies-Depression Scale (CES-D) at Week 10 (Value at Baseline Minus Value at Post Intervention (Week 10))
The CES-D is a validated self-report instrument of depressive symptoms. Scores range from 0 to 60 with higher values indicating more severe symptoms.
Change in score from baseline at post-intervention (week 10)
Study Arms (1)
ABC
EXPERIMENTALABC delivers therapy through 10, home-based, in-person sessions led by a trained professional. Treatment content is based on attachment theory and an understanding of children's stress neurobiology. Components aim to improve parental sensitivity, nurturance, and responsivity, as well as children's biological and behavioral reactivity through dyadic interactions between parents and children.
Interventions
ABC is a 10 session, home-based, dyadic therapy that is delivered by a trained professional. The sessions focus on improving the parent-child relationship and children's biological and behavioral responses to stress.
Eligibility Criteria
You may qualify if:
- Mothers between 18 and 50 years of age with heightened depressive symptoms as determined by a score of 16 or higher on the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R)
- Biological children (of mothers described above) between 2 and 4 years old with heightened internalizing symptoms as determined by a T-score of 60 or higher on the Childhood Behavior Checklist (CBCL)
You may not qualify if:
- Self-reported history of psychosis or active suicidality as defined by self-report of a specific suicide plan or recent attempt
- Current pregnancy
- Child diagnosis of autism
- Pacemaker implant, cardiac problems, cardiac medication
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of California, San Francisco
San Francisco, California, 94107, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Limitations and Caveats
Onset of the COVID-19 pandemic during the middle of the study. Some families completed the intervention in person and other families completed it virtually or a mix of in-person and virtual visits.
Results Point of Contact
- Title
- Danielle Roubinov, PhD
- Organization
- University of California, San Francisco
Study Officials
- PRINCIPAL INVESTIGATOR
Danielle Roubinov, PhD
University of California, San Francisco
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 7, 2019
First Posted
August 8, 2019
Study Start
August 1, 2020
Primary Completion
September 30, 2022
Study Completion
September 30, 2022
Last Updated
July 22, 2024
Results First Posted
July 22, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share